$0.660000
0.034.56%
At close: -
Comments
Loading...
Channel Therapeutics (CHRO) Forecast
NewsEarningsChannel Therapeutics (CHRO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestChannel Therapeutics (AMEX:CHRO) Stock Quotes, Forecast and News Summary
Channel Therapeutics Stock (AMEX: CHRO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Channel Therapeutics (CHRO) stock?
You can purchase shares of Channel Therapeutics (AMEX:CHRO) through any online brokerage.
Who are Channel Therapeutics (CHRO) competitors?
Other companies in Channel Therapeutics’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI), Portage Biotech (NASDAQ:PRTG) and AquaBounty Techs (NASDAQ:AQB).
What is the forecast, or price target, for Channel Therapeutics (CHRO) stock?
There is no analysis for Channel Therapeutics to provide a consensus price target.
What is the current price for Channel Therapeutics (CHRO)?
The stock price for Channel Therapeutics (AMEX: CHRO) is $0.6251 last updated November 22, 2024 at 5:54 PM EST.
Does Channel Therapeutics (CHRO) pay a dividend?
There are no upcoming dividends for Channel Therapeutics.
When is Channel Therapeutics (AMEX:CHRO) reporting earnings?
Channel Therapeutics’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is Channel Therapeutics (CHRO) going to split?
There is no upcoming split for Channel Therapeutics.
What sector and industry does Channel Therapeutics (CHRO) operate in?
Channel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.